Improving Reporting Standards in Adverse Event Analysis

This chapter emphasizes the critical need for improved reporting standards on adverse events in psychedelic studies to ensure better data quality. It explores the role of standardized forms in distinguishing between adverse events and complex therapeutic experiences, advocating for a cautious approach in clinical trial research.